• The majority of the breakthrough infections occurred in women
  • 160 deaths occurred in people between the ages of 71 to 89
  • The U.S. has fully vaccinated more than 130 million people: CDC

More than 10,000 fully vaccinated adults across 46 states and territories in the United States have contracted COVID-19, according to a Tuesday report from the Centers for Disease Control and Prevention.

The new information comes after the agency reported that more than 130 million Americans have been fully vaccinated against COVID-19.

Health officials in the U.S. reported a total of 10,262 COVID-19 infections among adults who were fully vaccinated against the virus. Among these cases, 6,446 of the vaccine breakthrough infections occurred in women between the ages of 40 to 74.

The CDC report also revealed that based on preliminary data, 27% of the infections were asymptomatic, 10% of the patients were hospitalized, and 2% or 160 people died.

However, the agency noted that among the 995 hospitalized patients, 289 were asymptomatic or hospitalized for reasons not related to COVID-19.

Among the patients who died, 28 were asymptomatic or died from causes not related to the novel coronavirus. The deaths occurred in people between the ages of 71 to 89.

According to White House senior COVID-19 adviser Andy Slavitt, 50% of adults in the U.S. have now been fully vaccinated, less than six months after the government launched the vaccination campaign.

"This is a major milestone in our country's vaccination efforts," Slavitt said in a Tuesday briefing." The number was 1% when we entered office Jan. 20," he added.

At least 70 million doses are being distributed nationwide, according to the CDC.

Vaccinations among children aged 12 and above have also risen sharply after the U.S. Food and Drug Administration granted emergency use authorization to the COVID-19 vaccine developed by Pfizer/BioNTech.

The latest data from the CDC’s Covid Data Tracker also showed that roughly five million adolescents have received at least one dose of the vaccine.

Meanwhile, Moderna on Tuesday said its vaccine is safe and effective in adolescents. The drugmaker said it plans to apply for authorization to use the vaccine in people ages 12 to 17 in early June.

Moderna’s clinical trial involved 3,732 adolescents who were given two doses of either the COVID-19 vaccine or placebo. During the trial, none of the participants developed coronavirus.

The Pfizer/BioNTech vaccine has been gaining popularity in France
The Pfizer/BioNTech vaccine has been gaining popularity in France AFP / BERTRAND GUAY